Folic Acid Supplementation: What is New? Fetal, Obstetric, Long-Term Benefits and Risks

References

• Centers for Disease Control and Prevention (CDC) . Spina bifida and anencephaly before and after folic acid mandate – United States, 1995–1996 and 1999–2000. MMWR Morb. Mortal. Wkly Rep.53, 363–365 (2004).
   Google Scholar
• Greene ND , StanierP, MooreGE. The emerging role of epigenetic mechanisms in the etiology of neural tube defects. Epigenetics6(7), 875–883 (2011).
   PubMed Web of Science ®Google Scholar
• Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet338(8760), 131–137 (1991).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC) . Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm. Rep.41, 1–7 (1992).
   Google Scholar
• Crane NT , WilsonDB, CookDA, LewisCJ, YetleyEA, RaderJI. Evaluating food fortification options: general principles revisited with folic acid. Am. J. Public Health85(5), 660–666 (1995).
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration . Authors Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final Rule. 21 CFR Parts 136, 137, and 139. Fed. Regist.61, 8781–8789 (1996).
   Google Scholar
• Williams J , MaiCT, MulinareJet al. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification – United States, 1995–2011. MMWR Morb. Mortal. Wkly. Rep.64(1), 1–5 (2015).
   PubMed Web of Science ®Google Scholar
• Centers for Disease C, Prevention . Folate status in women of childbearing age, by race/ethnicity – United States, 1999–2000, 2001–2002, and 2003–2004. MMWR Morb. Mortal. Wkly. Rep.55(51–52), 1377–1380 (2007).
   PubMedGoogle Scholar
• Blanck HM , GillespieC, SerdulaMK, KhanLK, GaluskDA, AinsworthBE. Use of low-carbohydrate, high-protein diets among americans: correlates, duration, and weight loss. MedGenMed8(2), 5 (2006).
   PubMedGoogle Scholar
• Quinlivan EP , GregoryJF3rd. Reassessing folic acid consumption patterns in the United States (1999 2004): potential effect on neural tube defects and overexposure to folate. Am. J. Clin. Nutr.86(6), 1773–1779 (2007).
   PubMed Web of Science ®Google Scholar
• Force USPST . Folic acid for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. Ann. Intern. Med.150(9), 626–631 (2009).
   PubMed Web of Science ®Google Scholar
• Sweeney MR , StainesA, DalyLet al. Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification? BMC Public Health 9, 295 (2009).
   PubMed Web of Science ®Google Scholar
• Wald NJ , LawMR, MorrisJK, WaldDS. Quantifying the effect of folic acid. Lancet358(9298), 2069–2073 (2001).
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Practice Bulletins . ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 44, July 2003. (Replaces Committee Opinion Number 252, March 2001). Obstet. Gynecol.102(1), 203–213 (2003).
   PubMedGoogle Scholar
• Nutrition in Pregnancy: Scientific Impact Paper No. 18. www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/sip_18.pdf.
   Google Scholar
• Healthy eating and vitamin supplements in pregnancy. www.rcog.org.uk/globalassets/documents/patients/patient-information-leaflets/pregnancy/pi-healthy-eating-and-vitamin-supplements-in-pregnancy.pdf.
   Google Scholar
• SOGC Clinical PracticeGuideline. No 324. http://sogc.org/wp-content/uploads/2015/06/gui324CPG1505E.pdf.
   Google Scholar
• Kaplan PW , NorwitzER, Ben-MenachemEet al. Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav.11(3), 283–291 (2007).
   PubMed Web of Science ®Google Scholar
• Yerby MS . Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology55(5 Suppl. 1), S21–S31; discussion S54–S28 (2000).
   PubMed Web of Science ®Google Scholar
• Hart LA , SibaiBM. Seizures in pregnancy: epilepsy, eclampsia, and stroke. Semin. Perinatol.37(4), 207–224 (2013).
   PubMed Web of Science ®Google Scholar
• Wlodarczyk BJ , PalaciosAM, GeorgeTM, FinnellRH. Antiepileptic drugs and pregnancy outcomes. Am. J. Med. Genet. A158A(8), 2071–2090 (2012).
   PubMed Web of Science ®Google Scholar
• Robert E , GuibaudP. Maternal valproic acid and congenital neural tube defects. Lancet2(8304), 937 (1982).
   PubMed Web of Science ®Google Scholar
• Kallen AJ . Maternal carbamazepine and infant spina bifida. Reprod. Toxicol.8(3), 203–205 (1994).
   PubMed Web of Science ®Google Scholar
• Little BB , Santos-RamosR, NewellJF, MaberryMC. Megadose carbamazepine during the period of neural tube closure. Obstet. Gynecol.82(Pt 2 Suppl. 4), 705–708 (1993).
   PubMed Web of Science ®Google Scholar
• Rosa FW . Spina bifida in infants of women treated with carbamazepine during pregnancy. N. Engl. J. Med.324(10), 674–677 (1991).
   PubMed Web of Science ®Google Scholar
• ACOG educational bulletin. Seizure disorders in pregnancy. Number 231, December 1996. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet.56(3), 279–286 (1997).
   PubMedGoogle Scholar
• Nunes VD , SawyerL, NeilsonJ, SarriG, CrossJH. Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance. BMJ344, e281 (2012).
   PubMedGoogle Scholar
• Wilson RD , LangloisD, American Congress of Obstetricians and Gynecologists, The Society of Obstetricians and Gynecologists of Canada and The Society of Gynecologic Oncologists of Canada. Genetic considerations for a woman’s annual gynaecological examination. J. Obstet. Gynaecol. Can.34(3), 276–284 (2012).
   PubMedGoogle Scholar
• Wen SW , ChenXK, RodgerMet al. Folic acid supplementation in early second trimester and the risk of pre-eclampsia. Am. J. Obstet. Gynecol.198(1), 45e41–47e41 (2008).
   Web of Science ®Google Scholar
• Cotter AM , MolloyAM, ScottJM, DalySF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe pre-eclampsia. Am. J. Obstet. Gynecol.185(4), 781–785 (2001).
   PubMed Web of Science ®Google Scholar
• Dodds L , FellDB, DooleyKCet al. Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes. Clin. Chem.54(2), 326–334 (2008).
   PubMed Web of Science ®Google Scholar
• Makedos G , PapanicolaouA, HitoglouAet al. Homocysteine, folic acid and B12 serum levels in pregnancy complicated with pre-eclampsia. Arch. Gynecol. Obstet.275(2), 121–124 (2007).
   PubMedGoogle Scholar
• Mujawar SA , PatilVW, DaverRG. Study of serum homocysteine, folic Acid and vitamin b(12) in patients with pre-eclampsia. Indian J. Clin. Biochem.26(3), 257–260 (2011).
   PubMedGoogle Scholar
• Roberts JM , CooperDW. Pathogenesis and genetics of pre-eclampsia. Lancet357(9249), 53–56 (2001).
   PubMed Web of Science ®Google Scholar
• Sanchez SE , ZhangC, Rene MalinowM, Ware-JaureguiS, LarrabureG, WilliamsMA. Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. Am. J. Epidemiol.153(5), 474–480 (2001).
   PubMed Web of Science ®Google Scholar
• Sorensen TK , MalinowMR, WilliamsMA, KingIB, LuthyDA. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of pre-eclampsia. Gynecol. Obstet. Invest.48(2), 98–103 (1999).
   PubMed Web of Science ®Google Scholar
• Van Pampus MG , DekkerGA, WolfHet al. High prevalence of hemostatic abnormalities in women with a history of severe pre-eclampsia. Am. J. Obstet. Gynecol.180(5), 1146–1150 (1999).
   PubMed Web of Science ®Google Scholar
• Chuang CZ , BoylesA, LegardeurB, SuJ, JapaS, LopezSA. Effects of riboflavin and folic acid supplementation on plasma homocysteine levels in healthy subjects. Am. J. Med. Sci.331(2), 65–71 (2006).
   PubMed Web of Science ®Google Scholar
• De Bree A , VerschurenWM, BlomHJ, KromhoutD. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am. J. Epidemiol.154(2), 150–154 (2001).
   PubMed Web of Science ®Google Scholar
• Scorsatto M , UeharaSK, LuizRR, De OliveiraGM, RosaG. Fortification of flours with folic acid reduces homocysteine levels in Brazilian women. Nutr. Res.31(12), 889–895 (2011).
   PubMed Web of Science ®Google Scholar
• Yamamoto K , IsaY, NakagawaT, HayakawaT. Folic acid fortification ameliorates hyperhomocysteinemia caused by a vitamin B(6)-deficient diet supplemented with L-methionine. Biosci. Biotechnol. Biochem.76(10), 1861–1865 (2012).
   PubMed Web of Science ®Google Scholar
• Bodnar LM , TangG, NessRB, HargerG, RobertsJM. Periconceptional multivitamin use reduces the risk of pre-eclampsia. Am. J. Epidemiol.164(5), 470–477 (2006).
   PubMed Web of Science ®Google Scholar
• Hernandez-Diaz S , WerlerMM, LouikC, MitchellAA. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am. J. Epidemiol.156(9), 806–812 (2002).
   PubMed Web of Science ®Google Scholar
• Li Z , YeR, ZhangL, LiH, LiuJ, RenA. Folic acid supplementation during early pregnancy and the risk of gestational hypertension and pre-eclampsia. Hypertension61(4), 873–879 (2013).
   PubMed Web of Science ®Google Scholar
• Timmermans S , JaddoeVW, SilvaLMet al. Folic acid is positively associated with uteroplacental vascular resistance: the Generation R study. Nutr. Metab. Cardiovasc. Dis.21(1), 54–61 (2011).
   PubMed Web of Science ®Google Scholar
• Andres E , GoichotB, SchliengerJL. Food cobalamin malabsorption: a usual cause of vitamin B12 deficiency. Arch. Intern. Med.160(13), 2061–2062 (2000).
   PubMedGoogle Scholar
• Elia M . Oral or parenteral therapy for B12 deficiency. Lancet352(9142), 1721–1722 (1998).
   PubMed Web of Science ®Google Scholar
• Victor Hoffbrand A , DanielCatovsky, EdwardGD. Tuddenham and Anthony R. Green. Postgraduate Haematology (6th Edition). Wiley Online Library (2010).
   Google Scholar
• Rolschau J , DateJ, KristoffersenK. Folic acid supplement and intrauterine growth. Acta Obstet. Gynecol. Scand.58(4), 343–346 (1979).
   PubMed Web of Science ®Google Scholar
• Pritchard JA , McDonaldPC. Megaloblastic Anemia (16th Edition). Appelton-Century-Crofts, New York, NY, USA, 717 (1980).
   Google Scholar
• Sifakis S , PharmakidesG. Anemia in pregnancy. Ann. NY Acad. Sci.900, 125–136 (2000).
   PubMed Web of Science ®Google Scholar
• Nelen WL , BlomHJ, SteegersEA, Den HeijerM, ThomasCM, EskesTK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet. Gynecol.95(4), 519–524 (2000).
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists . ACOG Practice Bulletin No. 95: Anemia in Pregnancy. Obstet. Gynecol.112, 201 (2008).
   PubMedGoogle Scholar
• American College of Obstetricians and Gynecologists . ACOG practice bulletin no. 134: fetal growth restriction. Obstet. Gynecol.121, 1122 (2013).
   PubMed Web of Science ®Google Scholar
• Baumslag N , EdelsteinT, MetzJ. Reduction of incidence of prematurity by folic acid supplementation in pregnancy. Br. Med. J.1(5687), 16–17 (1970).
   PubMedGoogle Scholar
• Fawzi WW , MsamangaGI, UrassaWet al. Vitamins and perinatal outcomes among HIV-negative women in Tanzania. N. Engl. J. Med.356(14), 1423–1431 (2007).
   PubMed Web of Science ®Google Scholar
• Goldenberg RL , TamuraT, CliverSP, CutterGR, HoffmanHJ, CopperRL. Serum folate and fetal growth retardation: a matter of compliance?Obstet. Gynecol.79(5 Pt 1), 719–722 (1992).
   PubMed Web of Science ®Google Scholar
• Iyengar L , RajalakshmiK. Effect of folic acid supplement on birth weights of infants. Am. J. Obstet. Gynecol.122(3), 332–336 (1975).
   PubMed Web of Science ®Google Scholar
• Neggers YH , GoldenbergRL, TamuraT, CliverSP, HoffmanHJ. The relationship between maternal dietary intake and infant birthweight. Acta Obstet. Gynecol. Scand. Suppl.165, 71–75 (1997).
   PubMedGoogle Scholar
• Rolschau J , KristoffersenK, UlrichM, GrinstedP, SchaumburgE, FogedN. The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. Eur. J. Obstet. Gynecol. Reprod. Biol.87(2), 105–110; discussion 103–104 (1999).
   PubMed Web of Science ®Google Scholar
• Scholl TO , HedigerML, SchallJI, KhooCS, FischerRL. Dietary and serum folate: their influence on the outcome of pregnancy. Am. J. Clin. Nutr.63(4), 520–525 (1996).
   PubMed Web of Science ®Google Scholar
• Tamura T , GoldenbergRL, FreebergLE, CliverSP, CutterGR, HoffmanHJ. Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. Am. J. Clin. Nutr.56(2), 365–370 (1992).
   PubMed Web of Science ®Google Scholar
• Ronnenberg AG , GoldmanMB, ChenDet al. Preconception homocysteine and B vitamin status and birth outcomes in Chinese women. Am. J. Clin. Nutr.76(6), 1385–1391 (2002).
   PubMed Web of Science ®Google Scholar
• Lassi ZS , SalamRA, HaiderBA, BhuttaZA. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst. Rev.3, CD006896 (2013).
   PubMed Web of Science ®Google Scholar
• Fekete K , BertiC, TrovatoMet al. Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth weight, placental weight and length of gestation. Nutr. J.11, 75 (2012).
   PubMed Web of Science ®Google Scholar
• Timmermans S , JaddoeVW, HofmanA, Steegers-TheunissenRP, SteegersEA. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. Br. J. Nutr.102(5), 777–785 (2009).
   PubMed Web of Science ®Google Scholar
• Hodgetts VA , MorrisRK, FrancisA, GardosiJ, IsmailKM. Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis. BJOG122(4), 478–490 (2015).
   PubMed Web of Science ®Google Scholar
• Levy SE , MandellDS, SchultzRT. Autism. Lancet374(9701), 1627–1638 (2009).
   PubMed Web of Science ®Google Scholar
• Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders – Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill. Summ.61, 1–19 (2012).
   Google Scholar
• Roth C , MagnusP, SchjolbergSet al. Folic acid supplements in pregnancy and severe language delay in children. JAMA306(14), 1566–1573 (2011).
   PubMed Web of Science ®Google Scholar
• Suren P , RothC, BresnahanMet al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA309(6), 570–577 (2013).
   PubMed Web of Science ®Google Scholar
• O’Roak BJ , StateMW. Autism genetics: strategies, challenges, and opportunities. Autism Res.1(1), 4–17 (2008).
   PubMed Web of Science ®Google Scholar
• O’Roak BJ , VivesL, FuWet al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science338(6114), 1619–1622 (2012).
   PubMed Web of Science ®Google Scholar
• Gardener H , SpiegelmanD, BukaSL. Prenatal risk factors for autism: comprehensive meta-analysis. Br. J. Psychiatry195(1), 7–14 (2009).
   PubMed Web of Science ®Google Scholar
• Christian P , Murray-KolbLE, KhatrySKet al. Prenatal micronutrient supplementation and intellectual and motor function in early school-aged children in Nepal. JAMA304(24), 2716–2723 (2010).
   PubMed Web of Science ®Google Scholar
• Schmidt RJ , TancrediDJ, OzonoffSet al. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case–control study. Am. J. Clin. Nutr.96(1), 80–89 (2012).
   PubMed Web of Science ®Google Scholar
• Meador KJ , BakerGA, BrowningNet al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol.12(3), 244–252 (2013).
   PubMed Web of Science ®Google Scholar
• Meador KJ , BakerGA, BrowningNet al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatrics168(8), 729–736 (2014).
   PubMed Web of Science ®Google Scholar
• Campbell NR . How safe are folic acid supplements?Arch. Intern. Med.156(15), 1638–1644 (1996).
   PubMedGoogle Scholar
• Hunter R , BarnesJ, OakeleyHF, MatthewsDM. Toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet1(7637), 61–63 (1970).
   PubMed Web of Science ®Google Scholar
• Hellstrom L . Lack of toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet1(7689), 59–61 (1971).
   PubMed Web of Science ®Google Scholar
• Richens A . Toxicity of folic acid. Lancet1(7705), 912 (1971).
   PubMed Web of Science ®Google Scholar
• Haberg SE , LondonSJ, StigumH, NafstadP, NystadW. Folic acid supplements in pregnancy and early childhood respiratory health. Arch. Dis. Child.94(3), 180–184 (2009).
   PubMed Web of Science ®Google Scholar
• Whitrow MJ , MooreVM, RumboldAR, DaviesMJ. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am. J. Epidemiol.170(12), 1486–1493 (2009).
   PubMed Web of Science ®Google Scholar
• Kelly P , McpartlinJ, GogginsM, WeirDG, ScottJM. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am. J. Clin. Nutr.65(6), 1790–1795 (1997).
   PubMed Web of Science ®Google Scholar
• Dunstan JA , WestC, MccarthySet al. The relationship between maternal folate status in pregnancy, cord blood folate levels, and allergic outcomes in early childhood. Allergy67(1), 50–57 (2012).
   PubMed Web of Science ®Google Scholar
• Magdelijns FJ , MommersM, PendersJ, SmitsL, ThijsC. Folic acid use in pregnancy and the development of atopy, asthma, and lung function in childhood. Pediatrics128(1), e135–e144 (2011).
   PubMed Web of Science ®Google Scholar
• Martinussen MP , RisnesKR, JacobsenGW, BrackenMB. Folic acid supplementation in early pregnancy and asthma in children aged 6 years. Am. J. Obstet. Gynecol.206(1), 72 e71–77 e71 (2012).
   Web of Science ®Google Scholar
• Butterworth CE Jr , HatchKD, MacalusoMet al. Folate deficiency and cervical dysplasia. JAMA267(4), 528–533 (1992).
   PubMed Web of Science ®Google Scholar
• Charles D , NessAR, CampbellD, Davey SmithG, HallMH. Taking folate in pregnancy and risk of maternal breast cancer. BMJ329(7479), 1375–1376 (2004).
   PubMedGoogle Scholar
• Zhang S , HunterDJ, HankinsonSEet al. A prospective study of folate intake and the risk of breast cancer. JAMA281(17), 1632–1637 (1999).
   PubMed Web of Science ®Google Scholar
• Mason JB , DicksteinA, JacquesPFet al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol. Biomarkers Prev.16(7), 1325–1329 (2007).
   PubMed Web of Science ®Google Scholar
• Cole BF , BaronJA, SandlerRSet al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA297(21), 2351–2359 (2007).
   PubMed Web of Science ®Google Scholar
• Czeizel AE , DudasI. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med.327(26), 1832–1835 (1992).
   PubMed Web of Science ®Google Scholar
• Czeizel AE , VarghaP. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am. J. Obstet. Gynecol.191(3), 790–794 (2004).
   PubMed Web of Science ®Google Scholar
• Ericson A , KallenB, AbergA. Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Res.4(2), 63–66 (2001).
   PubMedGoogle Scholar
• Li Z , GindlerJ, WangHet al. Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study. Lancet361(9355), 380–384 (2003).
   PubMed Web of Science ®Google Scholar